Reposted by Zach Epstein-Peterson
Steph Curry Finally Finishes Eating Mouthguard
January 6, 2026 at 10:00 PM
Steph Curry Finally Finishes Eating Mouthguard
Reposted by Zach Epstein-Peterson
Congestion pricing is working. The cameras are staying on.
January 5, 2026 at 3:28 PM
Congestion pricing is working. The cameras are staying on.
Reposted by Zach Epstein-Peterson
Pancreatic cancer is still one of the deadliest cancers. However, there are promising strategies currently under investigation that have been delayed or harmed because of the Trump administration and Elon Musk's DOGE.
CDMRP cuts left no money for many forms of cancer research including pancreatic.
CDMRP cuts left no money for many forms of cancer research including pancreatic.
Former Nebraska U.S. Sen. Ben Sasse on Tuesday said he was diagnosed with advanced pancreatic cancer. https://to.pbs.org/49cDtIV
Former Nebraska U.S. Sen. Ben Sasse says he has stage-four pancreatic cancer
Sasse expressed determination to fight the disease, highlighting advancements in immunotherapy and other treatments as part of his hope.
www.pbs.org
December 23, 2025 at 9:45 PM
Pancreatic cancer is still one of the deadliest cancers. However, there are promising strategies currently under investigation that have been delayed or harmed because of the Trump administration and Elon Musk's DOGE.
CDMRP cuts left no money for many forms of cancer research including pancreatic.
CDMRP cuts left no money for many forms of cancer research including pancreatic.
Reposted by Zach Epstein-Peterson
It’s the “season of love and giving”…but this year, doesn’t it seem more like a “season of fear and taking”? Like many of you, I’ve been saddened by the human impact of draconian government budget cuts and how angry many housed Americans are at unhoused Americans.
🧵 1 of 9
🧵 1 of 9
December 21, 2025 at 2:51 AM
It’s the “season of love and giving”…but this year, doesn’t it seem more like a “season of fear and taking”? Like many of you, I’ve been saddened by the human impact of draconian government budget cuts and how angry many housed Americans are at unhoused Americans.
🧵 1 of 9
🧵 1 of 9
Reposted by Zach Epstein-Peterson
🚨 UPDATE: The @fda.gov has approved a new therapy for #marginalzonelymphoma. The approval is based on results from a phase 2 clinical trial led by Dr. Lia Palomba, a hematologist-oncologist at MSK.
Learn more: bit.ly/4iVd9Y6
Learn more: bit.ly/4iVd9Y6
December 15, 2025 at 8:22 PM
🚨 UPDATE: The @fda.gov has approved a new therapy for #marginalzonelymphoma. The approval is based on results from a phase 2 clinical trial led by Dr. Lia Palomba, a hematologist-oncologist at MSK.
Learn more: bit.ly/4iVd9Y6
Learn more: bit.ly/4iVd9Y6
Reposted by Zach Epstein-Peterson
Happy Hanukkah x 1
חג אורים שמח
Never let them steal your joy.
חג אורים שמח
Never let them steal your joy.
December 15, 2025 at 12:37 AM
Happy Hanukkah x 1
חג אורים שמח
Never let them steal your joy.
חג אורים שמח
Never let them steal your joy.
Reposted by Zach Epstein-Peterson
While you were making fake Giannis trades… open.spotify.com/episode/0jDs...
While You Were Making Fake Giannis Trades: The Feisty Mavs, Deni’s Double Leap, and More. Plus, Who’s Cup Tough? | Group Chat
Spotify video
open.spotify.com
December 8, 2025 at 5:45 PM
While you were making fake Giannis trades… open.spotify.com/episode/0jDs...
Reposted by Zach Epstein-Peterson
Coming up at #ASH25: Join Dr. Andrew Intlekofer for a presentation on using enzyme hyperactivation to target oncometabolism in IDH-mutant #leukemia cells. @mskcancercenter.bsky.social @ash.hematology.org #leusm #lymsm #lymphoma
Learn more: bit.ly/48G5vfs
Learn more: bit.ly/48G5vfs
December 8, 2025 at 5:39 PM
Coming up at #ASH25: Join Dr. Andrew Intlekofer for a presentation on using enzyme hyperactivation to target oncometabolism in IDH-mutant #leukemia cells. @mskcancercenter.bsky.social @ash.hematology.org #leusm #lymsm #lymphoma
Learn more: bit.ly/48G5vfs
Learn more: bit.ly/48G5vfs
Reposted by Zach Epstein-Peterson
Tomorrow morning at #ASH25, Varun Iyengar, MD, will present a study evaluating venous thromboembolism risk factors found via genomic profiling cross subtypes of B-cell #lymphoma. @mskcancercenter.bsky.social @ash.hematology.org #lymsm
Learn more: bit.ly/4pucLmc
Learn more: bit.ly/4pucLmc
December 5, 2025 at 9:40 PM
Tomorrow morning at #ASH25, Varun Iyengar, MD, will present a study evaluating venous thromboembolism risk factors found via genomic profiling cross subtypes of B-cell #lymphoma. @mskcancercenter.bsky.social @ash.hematology.org #lymsm
Learn more: bit.ly/4pucLmc
Learn more: bit.ly/4pucLmc
Reposted by Zach Epstein-Peterson
At #ASH25, join #lymphoma specialist Quinlan Sievers to learn about molecular and structural basis of pan-resistance to BTK targeting therapies via BTK A428D mutation. #lymsm @mskcancercenter.bsky.social @ash.hematology.org
TODAY | 4:32 p.m. ET
Learn more: bit.ly/48PRRb3
TODAY | 4:32 p.m. ET
Learn more: bit.ly/48PRRb3
December 5, 2025 at 7:30 PM
At #ASH25, join #lymphoma specialist Quinlan Sievers to learn about molecular and structural basis of pan-resistance to BTK targeting therapies via BTK A428D mutation. #lymsm @mskcancercenter.bsky.social @ash.hematology.org
TODAY | 4:32 p.m. ET
Learn more: bit.ly/48PRRb3
TODAY | 4:32 p.m. ET
Learn more: bit.ly/48PRRb3
Reposted by Zach Epstein-Peterson
The FDA just approved the CAR T cell therapy lisocabtagene maraleucel for adults with relapsed or refractory marginal zone #lymphoma. Congratulations to study investigator M. Lia Palomba! #lymsm @mskcancercenter.bsky.social
FDA approves lisocabtagene maraleucel for relapsed or refractory margi
On December 4, 2025, the Food and Drug Administration approved lisocabtagene maraleucel (Breyanzi, Juno Therapeutics, Inc., a Bristol-Myers Squibb Company) for
www.fda.gov
December 5, 2025 at 4:19 PM
The FDA just approved the CAR T cell therapy lisocabtagene maraleucel for adults with relapsed or refractory marginal zone #lymphoma. Congratulations to study investigator M. Lia Palomba! #lymsm @mskcancercenter.bsky.social
Reposted by Zach Epstein-Peterson
Dear all; this year I will once again be riding in @cycleforsurvival.bsky.social to support research for rare cancers at @mskcancercenter.bsky.social. Rare cancers get very little funding for research despite being 50% of all cancers. Support my ride here: secure2.convio.net/mskcc/site/T...
Cycle for Survival: The Movement to Beat Rare Cancers
Support rare cancer research at Memorial Sloan Kettering Cancer Center.
secure2.convio.net
December 2, 2025 at 7:47 PM
Dear all; this year I will once again be riding in @cycleforsurvival.bsky.social to support research for rare cancers at @mskcancercenter.bsky.social. Rare cancers get very little funding for research despite being 50% of all cancers. Support my ride here: secure2.convio.net/mskcc/site/T...
Reposted by Zach Epstein-Peterson
“No,” said Frog.
November 28, 2025 at 8:37 AM
“No,” said Frog.
Reposted by Zach Epstein-Peterson
Congratulations to Dr. Lorenzo Falchi of @mskcancercenter.bsky.social on the FDA approval of epcoritamab-bysp with lenalidomide and rituximab for adults with relapsed or refractory follicular #lymphoma! A huge win for those with the condition. Dr. Falchi will present phase 3 trial data at #ASH25.
The @fda.gov approved the immunotherapy epcoritamab-bysp with lenalidomide and rituximab for relapsed or refractory follicular lymphoma: buff.ly/JNJZKMb
FDA approves epcoritamab-bysp for follicular lymphoma indications
FDA approves epcoritamab-bysp for follicular lymphoma indications
www.fda.gov
November 18, 2025 at 7:14 PM
Congratulations to Dr. Lorenzo Falchi of @mskcancercenter.bsky.social on the FDA approval of epcoritamab-bysp with lenalidomide and rituximab for adults with relapsed or refractory follicular #lymphoma! A huge win for those with the condition. Dr. Falchi will present phase 3 trial data at #ASH25.
Reposted by Zach Epstein-Peterson
In this manuscript, online today in Cancer Discovery, we investigate target-mediated resistance to ADCs, and propose ways to overcome it.
aacrjournals.org/cancerdiscov...
aacrjournals.org/cancerdiscov...
Trastuzumab Deruxtecan (T-DXd) Resistance via Loss of HER2 Expression and Binding
Abstract. T-DXd is clinically beneficial in HER2 positive and HER2 low metastatic breast cancer. However, therapeutic resistance emerges over time in most patients, with poorly defined resistance mech...
aacrjournals.org
November 10, 2025 at 4:55 PM
In this manuscript, online today in Cancer Discovery, we investigate target-mediated resistance to ADCs, and propose ways to overcome it.
aacrjournals.org/cancerdiscov...
aacrjournals.org/cancerdiscov...
Reposted by Zach Epstein-Peterson
just a reminder that the 8 Dems who folded need to vote again later in the week (thanks to dumb senate procedure, unsurprisingly)
light their phones up tomorrow at 9AM
light their phones up tomorrow at 9AM
BREAKING
The 1st Circuit REJECTS Trump DOJ's request to pause a judge's order to pay up Nov's SNAP funds to the states.
The SCOTUS stay will expire within 48 hours absent further action from the justices, per its terms.
Doc ecf.ca1.uscourts.gov/n/beam/servl...
The 1st Circuit REJECTS Trump DOJ's request to pause a judge's order to pay up Nov's SNAP funds to the states.
The SCOTUS stay will expire within 48 hours absent further action from the justices, per its terms.
Doc ecf.ca1.uscourts.gov/n/beam/servl...
November 10, 2025 at 5:46 AM
just a reminder that the 8 Dems who folded need to vote again later in the week (thanks to dumb senate procedure, unsurprisingly)
light their phones up tomorrow at 9AM
light their phones up tomorrow at 9AM
Reposted by Zach Epstein-Peterson
Toad took all of the buttons out of his pocket. He took his sewing box down from the shelf. Toad sewed the buttons all over his jacket.
November 5, 2025 at 2:37 PM
Toad took all of the buttons out of his pocket. He took his sewing box down from the shelf. Toad sewed the buttons all over his jacket.
Reposted by Zach Epstein-Peterson
BREAKING: Colorado voters approved a ballot measure that would raise state income taxes on higher-earning households to fund free meals for all public school students.
Follow AP for live updates.
Follow AP for live updates.
Live updates: US voters head to the polls in first general election since Trump's return to power
One year after Donald Trump retook the presidency, 2025 Election Day includes closely watched races for New York City mayor, New Jersey governor and California's Proposition 50.
bit.ly
November 5, 2025 at 3:33 AM
BREAKING: Colorado voters approved a ballot measure that would raise state income taxes on higher-earning households to fund free meals for all public school students.
Follow AP for live updates.
Follow AP for live updates.
Reposted by Zach Epstein-Peterson
Congratulations to this year’s recipients of the MSK 2025 Paul Marks Prize for Cancer Research: Dr. @oawlab.bsky.social, of MSK; Dr. Andrea Ablasser, of EPFL; and Dr. Christina Curtis, of @stanfordmedicine.bsky.social.
Learn more about the winners: bit.ly/47y8HLb
Learn more about the winners: bit.ly/47y8HLb
November 4, 2025 at 2:42 PM
Congratulations to this year’s recipients of the MSK 2025 Paul Marks Prize for Cancer Research: Dr. @oawlab.bsky.social, of MSK; Dr. Andrea Ablasser, of EPFL; and Dr. Christina Curtis, of @stanfordmedicine.bsky.social.
Learn more about the winners: bit.ly/47y8HLb
Learn more about the winners: bit.ly/47y8HLb
Reposted by Zach Epstein-Peterson
November is National Healthy Skin Month, and who better to get you thinking about skin care than #NYC's favorite dermatologist, Dr. Zizmor? We are used to seeing ads on the subway for medical services now, but when Dr. Zizmor began advertising in subway cars in the early 1980s, he was the first.
November 4, 2025 at 3:15 PM
November is National Healthy Skin Month, and who better to get you thinking about skin care than #NYC's favorite dermatologist, Dr. Zizmor? We are used to seeing ads on the subway for medical services now, but when Dr. Zizmor began advertising in subway cars in the early 1980s, he was the first.
Reposted by Zach Epstein-Peterson
The Interborough Express (IBX) has officially kicked off the Environmental Review process!
Join us at an upcoming Scoping Meeting to learn the latest about this transformative project that will connect currently underserved areas of Brooklyn and Queens.
Learn more and register here: mta.info/ibx
Join us at an upcoming Scoping Meeting to learn the latest about this transformative project that will connect currently underserved areas of Brooklyn and Queens.
Learn more and register here: mta.info/ibx
October 23, 2025 at 11:54 AM
The Interborough Express (IBX) has officially kicked off the Environmental Review process!
Join us at an upcoming Scoping Meeting to learn the latest about this transformative project that will connect currently underserved areas of Brooklyn and Queens.
Learn more and register here: mta.info/ibx
Join us at an upcoming Scoping Meeting to learn the latest about this transformative project that will connect currently underserved areas of Brooklyn and Queens.
Learn more and register here: mta.info/ibx
Reposted by Zach Epstein-Peterson
We're excited to share that Dr. Omar Abdel-Wahab, a leukemia specialist at MSK, has been elected to the @nam.edu.
With Dr. Abdel-Wahab’s appointment, a total of 28 MSK faculty members have been conferred with this recognition.
Congratulations, Dr. Abdel-Wahab!
bit.ly/49ezKw0
With Dr. Abdel-Wahab’s appointment, a total of 28 MSK faculty members have been conferred with this recognition.
Congratulations, Dr. Abdel-Wahab!
bit.ly/49ezKw0
Memorial Sloan Kettering Cancer Center Physician-Scientist Elected to the Prestigious National Academy of Medicine
Omar Abdel-Wahab, MD, Chair of the Molecular Pharmacology Program at Sloan Kettering Institute (SKI); Evnin Family Chair in Molecular Pharmacology and Attending Physician on the Leukemia Service at Me...
bit.ly
October 21, 2025 at 5:49 PM
We're excited to share that Dr. Omar Abdel-Wahab, a leukemia specialist at MSK, has been elected to the @nam.edu.
With Dr. Abdel-Wahab’s appointment, a total of 28 MSK faculty members have been conferred with this recognition.
Congratulations, Dr. Abdel-Wahab!
bit.ly/49ezKw0
With Dr. Abdel-Wahab’s appointment, a total of 28 MSK faculty members have been conferred with this recognition.
Congratulations, Dr. Abdel-Wahab!
bit.ly/49ezKw0
🧵
This is a pretty fair article, but it doesn't go far enough to make the connection as to why Zohran's foreign policy views are relevant for a local race as more than just a matter of disagreement with a large constituency.
Mamdani Is Making Overtures to Jewish Leaders. Some Are Listening.
www.nytimes.com
October 16, 2025 at 2:46 PM
🧵
Reposted by Zach Epstein-Peterson
At 7 years old, Emily became the first child in the world to receive CAR T-cell therapy. After three relapses and being sent to hospice, Emily got a second chance at life with this treatment. Help protect access to life-saving treatments: https://ow.ly/rXY150X5Tso
#Fight4Hematology #HemeSky
#Fight4Hematology #HemeSky
October 10, 2025 at 2:01 PM
At 7 years old, Emily became the first child in the world to receive CAR T-cell therapy. After three relapses and being sent to hospice, Emily got a second chance at life with this treatment. Help protect access to life-saving treatments: https://ow.ly/rXY150X5Tso
#Fight4Hematology #HemeSky
#Fight4Hematology #HemeSky
Reposted by Zach Epstein-Peterson
#OnThisDay in 1933, seven new stations opened on the IND Culver Line in Brooklyn (the F and G trains): Carroll Street, Smith-Ninth Street, Fourth Avenue, Seventh Avenue, 15th Street–Prospect Park, Fort Hamilton, and Church Avenue. These images show the line before, during, and after construction.
October 7, 2025 at 8:15 PM
#OnThisDay in 1933, seven new stations opened on the IND Culver Line in Brooklyn (the F and G trains): Carroll Street, Smith-Ninth Street, Fourth Avenue, Seventh Avenue, 15th Street–Prospect Park, Fort Hamilton, and Church Avenue. These images show the line before, during, and after construction.